Skip to content

Effects and neural mechanisms of repetitive transcranial magnetic stimulation on episodic memory in patients with subjective cognitive decline

Effects and neural mechanisms of repetitive transcranial magnetic stimulation on episodic memory in patients with subjective cognitive decline

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075517
Enrollment
Unknown
Registered
2023-09-07
Start date
2023-09-10
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment in the elderly

Interventions

treatment group of subjective cognitive decline(SCD) group:repetitive transcranial magnetic stimulation
control group of subjective cognitive decline(SCD) group :sham repetitive transcranial magnetic stimulation

Sponsors

The Affiliated JiangSu Shengze Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria are based on Jessen’s criteria as follows: (1) not meeting the diagnosis of MCI on the standardized neuropsychological tests, including memory, speed/executive function, and language domains; (2) self-perceived memory loss for at least 6 months; (3) presence of concern that performance in memory is worse than other people of the same age; (4) 55 to 80 years; (5)the subject signs the informed consent.

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows: (1) clinical diagnosis of vascular dementia (Modified Hachinski Ischemic Score > 4) or dementia (NINDS-AIREN criteria); (2) drug or alcohol dependence within the last 6 months; (3) presence of severe cardiovascular or cerebrovascular disease or psychiatric disease; (4) contraindications to TMS; (5) treatment with antidepressants, anxiolytics, or central nervous system medications within 3 months prior to the assessments; (6) geriatric depression scale scores = 6.

Design outcomes

Primary

MeasureTime frame
Auditory Verbal Learning Test-Huashan version (AVLT-H) ;

Secondary

MeasureTime frame
mini-mental state examination(MMSE);Wechsler Logical Memory Test ;wechsler digital memory span test ;Boston Naming Test China version(BNT-C) ;Animal Fluency test (AFT);Shape Trail Test-A China version(STT-A-C) ;Shape Trail Test-B China version(STT-B-C) ;Digit Symbol Substitution Test (DSST);motor cortex plasticity ;working memory(n-back) ;inhibition control(Go/No-Go) ;Montreal cognitive assessment (MoCA);

Countries

China

Contacts

Public ContactLu Qian

The Affiliated JiangSu Shengze Hospital of Nanjing Medical University

luqian424@126.com+86 159 5208 7698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026